Nkarta Therapeutics Raises $114 Million in Series B Financing to Advance Multiple Programs into Clinical Trials

NEXT STORY
Global & US Gene Therapy Market Outlook to 2020 – Rising Focus to Accelerate Commercialization of Gene Therapy in Developed Nations
PREV STORY
Orchestra BioMed Receives CE Mark for BackBeat Cardiac Neuromodulation Therapy™ (CNT) for Hypertension
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Precision Therapeutics, Inc. Engages Richard Gabriel to Drive Business Development Strategy for its TumorGenesis Subsidiary

author_avatar
NASDAQ Market News

Philips introduces the new Spectral Computed Tomography 7500 system, providing spectral information for every patient and every scan

author_avatar
NASDAQ Market News

Upsurge in Companion Pet Population Brings Need for Canine Blood Donors. Mount Laurel Animal Hospital Plans Canine Blood Drive.

author_avatar
NASDAQ Market News